+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 22Years - 75Years
All Genders
ID06429735

Early Feasibility Study of Neuralinks N1 Brain Implant and R1 Robot in Adults with Severe Tetraplegia or ALS

Led by Neuralink Corp · Updated on 2026-01-09

15

Participants Needed

2

Research Sites

239 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the Neuralink N1 Implant and R1 Robot device designs in people with tetraparesis or tetraplegia, including those with spinal cord injury or amyotrophic lateral sclerosis ALS. This early feasibility study aims to assess the initial clinical safety and how well these devices function. The N1 Implant is a wireless, rechargeable device mounted on the skull and connected to electrode threads implanted in the brain by the R1 Robot, a robotic inserter. Participants will receive the N1 Implant placed using the R1 Robot during a surgical procedure. The study does not mention multiple treatment groups or comparators. The focus is on the implantation and early use of the brain-computer interface device to help control external devices. This study is an early phase feasibility investigation without masking or blinding. During the study, participants will be monitored for device- and procedure-related adverse events at 12 months post-implant and up to 72 months for longer-term safety tracking. Researchers will assess clinical safety and device functionality over this extended period. Participants will need a stable caregiver, and the study includes follow-up visits and evaluations to monitor safety and device performance over several years.

CONDITIONS

Brief Title

Precise Robotically IMplanted Brain-Computer InterfacE

Research Team

N

Neuralink Clinical Team

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here